Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 150

1.

Evaluating the potential impact of vaginal microbicides to reduce the risk of acquiring HIV in female sex workers.

Smith RJ, Bodine EN, Wilson DP, Blower SM.

AIDS. 2005 Mar 4;19(4):413-21.

PMID:
15750395
2.

Shifts in condom use following microbicide introduction: should we be concerned?

Foss AM, Vickerman PT, Heise L, Watts CH.

AIDS. 2003 May 23;17(8):1227-37. Review.

PMID:
12819525
3.
4.

Care should be taken when promoting microbicide use among sex workers who are able to use condoms consistently: response to Smith et al. (2005).

Foss AM, Watts CH, Vickerman PT, Heise L.

AIDS. 2006 Jan 9;20(2):303-5. No abstract available.

PMID:
16511432
5.

Microbicide acceptability among female sex workers in Beijing, China: results from a pilot study.

Han L, Lv F, Xu P, Zhang G, Juniper NS, Wu Z.

J Womens Health (Larchmt). 2009 Sep;18(9):1377-84. doi: 10.1089/jwh.2008.1239.

6.

Response to Foss et al., 'Care should be taken when promoting microbicide use among sex workers who are able to use condoms consistently'.

Wilson DP, Bodine EN, Smith RJ, Blower SM.

AIDS. 2005 Nov 18;19(17):2044-6. No abstract available.

PMID:
16260916
7.

Optimizing HIV prevention for women: a review of evidence from microbicide studies and considerations for gender-sensitive microbicide introduction.

Doggett EG, Lanham M, Wilcher R, Gafos M, Karim QA, Heise L.

J Int AIDS Soc. 2015 Dec 21;18:20536. doi: 10.7448/IAS.18.1.20536. eCollection 2015. Review.

8.

Microbicides and HIV: help or hindrance?

Karmon E, Potts M, Getz WM.

J Acquir Immune Defic Syndr. 2003 Sep 1;34(1):71-5.

PMID:
14501797
9.

How much could a microbicide's sexually transmitted infection efficacy contribute to reducing HIV risk and the level of condom use needed to lower risk? Model estimates.

Foss AM, Vickerman PT, Alary M, Watts CH.

Sex Transm Infect. 2009 Aug;85(4):276-82. doi: 10.1136/sti.2008.032458. Epub 2009 Feb 10.

PMID:
19208696
10.

The acceptability of an investigational vaginal microbicide, PRO 2000 Gel, among women in a phase I clinical trial.

Morrow K, Rosen R, Richter L, Emans A, Forbes A, Day J, Morar N, Maslankowski L, Profy AT, Kelly C, Abdool Karim SS, Mayer KH.

J Womens Health (Larchmt). 2003 Sep;12(7):655-66.

PMID:
14583106
11.

Sexuality, HIV risk and potential acceptability of involving adolescent girls in microbicide research in Kisumu, Kenya.

Montandon M, Sahin-Hodoglugil NN, Bukusi E, Agot K, Boland B, Cohen CR.

Sex Health. 2008 Dec;5(4):339-46.

PMID:
19061553
13.

Communicating about microbicides with women in mind: tailoring messages for specific audiences.

Sidibe S, Pack AP, Tolley EE, Ryan E, Mackenzie C, Bockh E, Githuka G.

J Int AIDS Soc. 2014 Sep 8;17(3 Suppl 2):19151. doi: 10.7448/IAS.17.3.19151. eCollection 2014.

14.

Human immunodeficiency virus seroprevalence and condom use among female sex workers in Italy.

Spina M, Mancuso S, Sinicco A, Vaccher E, Traina C, Di Fabrizio N, De Lalla F, Tirelli U.

Sex Transm Dis. 1998 Oct;25(9):451-4.

PMID:
9800254
15.

Intravaginal practices and microbicide acceptability in Papua New Guinea: implications for HIV prevention in a moderate-prevalence setting.

Vallely A, Fitzgerald L, Fiya V, Aeno H, Kelly A, Sauk J, Kupul M, Neo J, Millan J, Siba P, Kaldor JM.

BMC Res Notes. 2012 Nov 1;5:613. doi: 10.1186/1756-0500-5-613.

16.

Desired qualities and hypothetical contextual use of vaginal microbicides in a diverse sample of US women.

Olsen ML, Cwiak CA, Koudelka C, Jensen JT.

Contraception. 2007 Oct;76(4):314-8. Epub 2007 Aug 28.

PMID:
17900444
17.

Challenges to microbicide introduction in South Africa.

Orner P, Harries J, Cooper D, Moodley J, Hoffman M, Becker J, McGrory E, Dabash R, Bracken H.

Soc Sci Med. 2006 Aug;63(4):968-78. Epub 2006 Apr 5.

PMID:
16600447
18.

Microbicide acceptability and associated factors among female sex workers and male clients in Kaiyuan county, Yunnan province, China.

Wang Y, Jiang Y, Lu L, Wang G, Bi A, Fang H, Chang D, Gu J, Wang W.

J Acquir Immune Defic Syndr. 2010 Feb;53 Suppl 1:S93-7. doi: 10.1097/QAI.0b013e3181c7de7b.

PMID:
20104117
19.

"We have our protector": misperceptions of protection against HIV among participants in a microbicide efficacy trial.

Mantell JE, Morar NS, Myer L, Ramjee G.

Am J Public Health. 2006 Jun;96(6):1073-7. Epub 2006 May 2.

20.

A dose-response relationship between exposure to a large-scale HIV preventive intervention and consistent condom use with different sexual partners of female sex workers in southern India.

Deering KN, Boily MC, Lowndes CM, Shoveller J, Tyndall MW, Vickerman P, Bradley J, Gurav K, Pickles M, Moses S, Ramesh BM, Washington R, Rajaram S, Alary M.

BMC Public Health. 2011 Dec 29;11 Suppl 6:S8. doi: 10.1186/1471-2458-11-S6-S8.

Supplemental Content

Support Center